The drug had been approved to treat cancer from asbestos exposure a few years ago. Since I am on the topic of lung cancer, I did an interview not too long ago about Rosetta Genomics, who has a test to diagnose “cancer of the unknown” in the lungs. Thousands never find out exactly what type of cancer they have and the test is about 99% accurate, why have the test, your treatment may vary depending upon the type of cancer you have. If cancer migrated from the liver for example, a different plan of action may be required with different drugs. BD
Rosetta Genomics Cancer Test now Available in 48 States – Cancer of the Unknown
The Food and Drug Administration (FDA) has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
Patients with cancer often receive maintenance therapy to prevent the disease from progressing after their tumor has shrunk or the disease has stabilized in response to chemotherapy. Alimta disrupts metabolic processes that are dependent on the B-vitamin folate, a necessary ingredient for cell reproduction.
Reported adverse events included damage to blood cells, fatigue, nausea, loss of appetite, tingling or numbness in the hands and feet, and skin rash.
Rosetta Genomics Interview – microRNA for Diagnosing Lung Cancer Tumors
0 comments :
Post a Comment